chrisvoncsefalvay/vaers-outcomes huggingface dataset:
03/15/2017 3:30PM-4:00PM CHILD COMPLAINS OF PAIN TO RIGHT ARM.  THERE WAS SWELLING TO UPPER RIGHT ARM AND TO THE INJECTION SITE,  LOW GRADE FEVER OF 99.8 F AND BANDAID WAS SATURATED WITH BLOOD.  4:30PM-4:45PM MOTHER CALLED HOSPITAL AND ADVISED TO CHANGE THE BANDAID.  5:00PM THE CHILD BECAME LETHARGIC AND NOT TALKING.  MOTHER TRANSPORTED THE CHILD TO HOSPITAL.  MOTHER REPORTS OBSERVED A RASH TO THE CHILD'S ARMS AND HANDS AT TIME OF TRANSPORT.  SHE DESCRIBED THE RASH AS A RED, BLOTCHY AND RAISED RASH WITH SWELLING TO THE HANDS.  TYLENOL WAS GIVEN AT 5:00PM BEFORE LEAVING FOR THE HOSPITAL.  CHILD WAS GIVEN BENADRYL AT 6:30PM AND MOTRIN AT 7:00PM WHILE BEING EVALUATED IN THE ER.  MOTHER REPORTS THE RASH WAS BEGINNING TO DIMINISH AT 9:30PM.  03/16/2017 3:00PM RECEIVED A TELEPHONE CALL FROM CHILD'S MOTHER TO REPORT THE SYMPTOMS HER SON EXPERIENCED AFTER RECEIVING IMMUNIZATIONS AT THE HEALTH DEPARTMENT THE PREVIOUS DAY AND TAKING CHILD TO THE ER FOR MANAGEMENT OF THE SYMPTOMS.  MOTHER STATES THE RASH IS RESOLVED AND CHILD STILL COMPLAINS OF PAIN TO UPPER RIGHT ARM AND TENDER TO TOUCH TO THE SITE OF THE INJECTION. SHE ALSO REPORTS THERE IS NO DRAINAGE TO THE SITE, BUT THERE IS A BRUISE LIKE DISCOLORATION AND MILD SWELLING.  THE CHILD ALSO DOES NOT HAVE A FEVER.
Sore injection site; This is a spontaneous report from a non-contactable healthcare professional.  A 29-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number EH9899), intramuscular into the left arm on 17Dec2020 at 06:15 as single dose for COVID-19 immunization.  There was no medical history.  The patient's concomitant medications were not reported.  The patient experienced sore injection site on 17Dec2020, at  14:00. The event was reported as non-serious. The outcome of sore injection site was recovered in Dec2020.
After a community vaccination clinic, it was discovered that there were 3 extra syringes. Staff could not remember how many they drew for the day out of the vial (10 or 11). One staff member remembered 2-3 vaccines being "easy" to give and began questioning if all the syringes had actual vaccine or not. Moderna contacted. Suggested not offering a 3rd vaccine due to data. Patients will be contacted and notified today about the incident and offered an antibody test if desired.
fatigue; head cold; head ache; light headedness; This is a spontaneous report from a contactable physician. An 87-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration on 14Feb2021 as single dose for covid-19 immunisation. Medical history included ongoing diabetes Type2, ongoing chronic obstructive pulmonary disease (COPD), ongoing neuropathy peripheral, ongoing heart attack, ongoing blood pressure control, ongoing hyperlipidemia. Concomitant medications included all ongoing metformin; metoprolol; pravastatin; gabapentin; asa; vitamins nos (MULTIVITAMINUM). The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on 24Jan2021 for COVID-19 Immunization. There is no prior vaccination. He did report that after the second dose (believe the second shot was 14Feb2021) and he had some head cold, fatigue, but no fever and had a dull headache and felt a light headedness he started at that time that this started 3 days after receiving vaccine (17Feb2021 or 18Feb2021). He took Tylenol which helped his symptoms. The patient stated that the light headedness he experienced did not keep him from doing his ADLS. The outcome of event lightheaded was resolved with in 2 days, the outcome of the other events was unknown.  No follow up attempts are possible; Information about lot/batch number cannot be obtained.
Donor report after 30 minutes of immunization administration, she felt shooting pain across right arm spreading to neck, head, across shoulder. Donor had trouble lifting her right arm and experience cramping in arm as well as dizziness and light headedness. She hydrated herself and ate a snack and after resting/sleeping the next day she felt better with soreness in R. arm. Today she states feeling back to normal.
Narrative:  50M with PMH MS, HLD, BPH, psoriasis, ED who presented to local hospital on 8/22/2021 for weakness and cough, was found to be positive with COVID19, pt was transferred to the local hospital for continued care. Prior to admission, patient had not required supplemental oxygen. Of note, this patient was COVID19 + in Nov 20202 and was hospitalized for almost 1 month (ICU, HFNC, he did not require intubation). Patient received both Moderna vaccines (March and April 2021). On day 2 of admission patient did require supplemental oxygen up to 4L NC for hypoxic respiratory failure. He was started on remdesivir and dexamethasone therapy. He finished a 5 day course of remdesivir, will finish dexamethasoen 9/3. Prior to d/c patient had walk test with RT and was found to not require supplemental oxygen.
pt recv vax 22MAY96 & 18DEC97 pt devel a breakthrough case;pt mom noted 10 spots on back & on 19DEC97 & had approx 20-22 vesicles in hairline, groin, abd & arms;mom also reported that every time looked had more spots;
fever of 102F; This case was reported by a other health professional via call center representative and described the occurrence of fever in a 58-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included cough (had cough prior to receiving vaccine).   On 25th November 2019, the patient received the 2nd dose of Shingrix. On 25th November 2019, less than a day after receiving Shingrix, the patient experienced fever. The patient was treated with antibiotics nos and paracetamol (Tylenol). On an unknown date, the outcome of the fever was not recovered/not resolved.   It was unknown if the reporter considered the fever to be related to Shingrix.  Additional details were provided as follows: The reporter was the physician's assistant reported on behalf of her father. The patient received dose of Shingrix in an unknown arm. On 25th November 2019, less than 12 hours after vaccination, the patient experienced fever of 102F. The reporter stated that, the patient had cough prior to receiving the vaccine and when the patient developed fever, the reporter called the doctor. The doctor prescribed antibiotics and also recommended to took Tylenol. The reporter stated that, the patient called his doctor to inform about his symptoms,  however, the patient did not visit the doctor's office. The reporter did not consent to folllow up.
A physician report concerns a 7 year old female patient. Concomitant medications and medical history were not reported. On 13-Nov-2014, the patient received FLUMIST (intranasal). The patient experienced paralysis facial on the same day. At the time of reporting, the paralysis facial was ongoing. The reporter considered the paralysis facial to be serious based on hospitalization.
Pt vaccinated with Engerix-B experienced general malaise, migraine headache, nausea, vomiting.
Information regarding PREVNAR was received from a healthcare professional who reported infants react in a way that suggests the injection is causing a high level of discomfort. The patient received a dose on an unspecified date. The reporter noted that infants react in a way that suggests the injection is causing a high level or discomfort. the outcome is unknown. See related case (s): US-WYE-H13405810 (adverse event, non-expedited). No additional information was available at the time of this report.
Presented to ED from nursing home with cough and shortness of breath with O2 saturation of 60% and hypotensive. Was given decadron, singulair, vitamin D, zinc, melatonin,  Later developed seizure and was very frightened and hallucinated Later tested negative for COVID-19 Discharged back to nursing home
Still having chills, fatigue, body aches, headaches, runny nose, nausea, swollen lymphnodes , some diarrhea , no appetite.
Palpitations; Really high heart rate; Chest pain; Had very high fever; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Palpitations), HEART RATE INCREASED (Really high heart rate), CHEST PAIN (Chest pain) and PYREXIA (Had very high fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PALPITATIONS (Palpitations), HEART RATE INCREASED (Really high heart rate), CHEST PAIN (Chest pain) and PYREXIA (Had very high fever). At the time of the report, PALPITATIONS (Palpitations), HEART RATE INCREASED (Really high heart rate), CHEST PAIN (Chest pain) and PYREXIA (Had very high fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: abnormal (abnormal) Blood tests were done and reported to have high levels of CRT and D-dimer.. On an unknown date, Computerised tomogram: normal (normal) Patient had undergone a contrast CT looking for pulmonary embolism but found that she did not have that.. On an unknown date, Fibrin D dimer: high (High) Elevated D-dimer.. On an unknown date, Heart rate: high (High) Heart rate increased..         No concomitant medications were reported. Treatment information was not provided.  The patient was recommended for the booster shot but she was concerned due to high reactions post second shot. Three days later she had visited her doctor because of the symptoms and had undergone lab tests including blood work where reported to have elevated level of CRT. The levels of CRT and D-dimer were still elevated and reported that it took 4 -5 weeks to get past from the symptoms.
Patient was given flu vaccination. About 5 minutes later, patient stated that vision was black, he looked pale, shaking, and cold to touch. 911 was called. Patient went to ER. No findings on lab results and no diagnosis was given. Parent was advised to follow-up with PCP if any new symptoms arise.
Information has been received from a physician concerning a 6 month old female who "2 months ago", in August 2007, received her second oral dose of RotaTeq vaccine. It was reported that after receiving the dose she developed diarrhea and vomiting. It was reported that the patient sought unspecified medical attention and had recovered. No product quality complaint was reported. No other information was available. Additional information has been requested.
On 09/23/23 I called the patient to administer 3 vaccinations. I confirmed her name as well as the vaccines we were going to administer. The vaccines are kept in separate basins for each patient and as I administered her vaccines/interacted with her, another nurse placed the next patients? vaccines close to same area I was working on for the current patient. As I was administering her vaccines and speaking with the patient, I grabbed what I thought was her next vaccine from her basin (as they were the same color) and grabbed a TDAP vaccine that was ready for the NEXT patient. I immediately realized what had happened after administering and explained to the patient what had happened. I apologized to her and went over possible side effects of getting an extra TDAP vaccine.
Pt vaccinated with DTP/OPV developed prolonged extreme irritability 4-5 hrs.
Diffuse generalized macular, papular rash. After 23 hours swelling in left arm and tender. Local rash.
Spoke with patient's daughter who states that since he received the Pfizer vaccine in April his health has declined. She states he was fairly healthy before receiving the vaccine and now has been seeing multiple doctors for his issues. States patient now has a neurologist due to having joint pain and shingles like sx without the presence of shingles. States patient is also having chest and back pain that is unexplained. Daughter states he has been hospitalized three times since July and that both his primary physician and neurologist think that his issues can be linked back to the Pfizer vaccine.
Bleeding, Myalgia, tingling in the fingers of the right hand; fatigue Immediately upon vaccination - bleeding at the injection site which the employee reports as filling the bandaid over the site. When she got home in the evening and took it off blood ran down her arm but the bleeding stopped immediately. This has resolved. 12/29 at about 2:00 employee reports onset of tingling in the fingers of her right hand - index, middle, ring, and pinky. For about 2 hours the tingling was intense. As of 12/30 this has markedly improved and the tingling is intermittent. Later in the evening of 12/29 she noticed the onset of muscle pains throughout her body but especially in her feet. She also became very fatigued. These symptoms linger on 12/30. On 1/1 employee reports symptoms muscle soreness had resolved. 1/4 tingling in her fingers/arm has improved but is still present. She will follow-up with her PCP if this symptom persists beyond 2-4 weeks.
Within hours post vax, the pt experienced pain in the injection arm down to the elbow and then down into his fingers. No treatment was given. The outcome of the event is ongoing.
Late evening after shot felt like was getting a cold, runny nose, tired.  Next day had fever, high of 100.0 F, joint pain, headache, fatigue. Lasted about 24 hours, improved by second day after shot with minor fatigue for another day, by  3rd day felt normal.
24FEB97 pt recv vax & had a red knot on leg where inj was given;the knot started Saturday & was the size of a nickle;the redness started Monday & was the size of a fifty cent piece;mom recalls leaving the bandaid on x 2 days;
pt recv vax 26FEB97 & on 4MAR97 pt exp lesions;
Patient claims that injection given (Fluzone Quad 15-16) was painful after receiving on 10/30/15 at approximately 6:15pm-- sore, slightly warm to the touch, red circle developed around site of injection.  Patient approached pharmacist first on 11/7/15 at approximately 1:30pm to inquire about injection site-- still red circular mark around area at that time (he said was fading some but still there, was very apparent to pharmacist), slightly warm to the touch at that point per patient report.  Pharmacist recommended that he seek advice of his family physician to evaluate to rule out infection or serious issue.  Patient was to report results back to pharmacist early in the week of 11/14/15-- he called patient back on 11/13/15 and state that he visited his family physician, and that he does not feel that there is anything medically wrong with the patient, and that it is just a bruise, possibly that the injection went into a vein that leaked out.  Patient states as of 11/13/15 that site is "just about gone," and much better, and no further assistance is needed at this time.
Vaccine Covid Pfizer dose 2 given 9/17/21 at 430pm. On 9/18/21 at 1030 pm- sharp chest pains began, they lasted all night. Chest pains more when laying down and became less severe as I sat up. Went to the ER at 0700 9/19/2021 after 9 hours of continuing chest pains.  9/19- only positive finding was enlarged lymph nodes on left side/ near breast where injection site was
received the first dose / on 10/21/2018 and had not yet received the second dose; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 52-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 21st October 2018, batch number-9de73, expiry date- 6th December 2021).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix vaccine which led to incomplete course of vaccination. No further events were reported. The health care professional agreed to be contacted for follow up. The reporter consented to follow up.
My menstrual cycle is completely disturbed since receiving the vaccines.  I have two periods per month.
Pain in armpit and upper back side of arm. Sore when touched. Swelling of lymph nodes in armpit. Soreness, swelling,  and pain decreasing over time but still present today, May 7th.
Redness and swelling next day, which resolved but 4 days later developed recurrent swellingwith nausea and vomiting
Vaccinated 3/23 at 1:30 p.m.  5 hr post: fatigue body aches mild. 9 hrs post Temp 101.7 increased joint pain, severe body aches nausea. Tylenol taken. Fever broke 18 hrs post. Felt better. on 3/24 at 12 noon 22 hrs post vaccination: HA, increased joint pain, body aches, fatigue. Temp 101.7. Tylenol taken.   At 4 p.m. Temp 100.1. Symptoms continued. At 8 p.m. 30 hrs post vaccine Temp: 102.7  Increased symptoms of joint pain, HA, fatigue, nausea.  3/25/21 Approximately 34 hrs post vaccine at 0015 a.m. Temp 103.4. Severe joint pain, full systemic body aches, fatigue, HA, nausea.  Tylenol taken w/continued increase fluids as tolerated.  Approximately 40 hrs post vaccine at 0600 significant diaphoresis, fever broke down to 100.2.  Slept 4 hrs. Awoke to temp 99.8 approximately 44 hrs post vaccine.  Employee health notified. Wanted VAERS report filed and also COVID 19 test done this day. (COVID Neg 3/25) On 3/26: Severe lower back pain occurred. One area only and non-radiating. Pain Sharp and burning. This was not typical chronic pain and it occurred without any trauma or significant event. This back pain lasted from 3/26 through a.m of 3/30. ( It was not relieved by any oral pain medication. It made any ADLs difficult. Unable to sleep due to pain.  It remained severe and constant until 3/30 in which it went away Phone call to  primary physician.  Back xrays were ordered and negative. Lab tests normal.
When I got the shot I had a little bit of sore arm then a couple weeks later, I would break out into sweat, fatigued and out of breath. I had full work up from cardiologist normal other then some preventrical beats. The heart looks strong and my echo actually improved.
husband contacted covid-19 in spite having their vaccination/lack of efficacy; husband contacted covid-19 in spite having their vaccination/lack of efficacy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group.  A 45 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 45 years as dose 3 (booster), single, (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 26Jan2022, outcome "unknown" and all described as "husband contacted covid-19 in spite having their vaccination/lack of efficacy". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: positive. Therapeutic measures were taken as a result of covid-19 included Tylenol.Reporter stated, she was a Pfizer employee. Concern, reporter stated, Her boss said because she have got contracted COVID that she was supposed to call and report it as a safety event since she was vaccinated. Adverse event experienced, reporter stated, She did not get any, she just didnt have efficacy so she actually got covid-19. Well her daughter she actually dont have positive test but her daughters and husband contacted covid-19 in spite having their vaccination. Anatomical site of vaccination: Reporter stated, Right. Medical conditions and other medications, reporter stated, Yes but she dont have them listed right now. (withheld) takes Zyrtec, (withheld) takes no, nothing and she dont have a list of medication for (withheld). This was the second case out of four cases in which reporter was reporting for her husband.   The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200157655 same AE/drug, different patient
This spontaneous report was received from a 55 year old female patient referring on herself. The patient had no pertinent medical history nor drug/reaction allergies. On 20-OCT-2014 the patient was vaccinated with PNEUMOVAX 23 in the right arm. Dose, route, lot number and expiration date were not reported. There was no concomitant medication. The patient reported that after receiving the PNEUMOVAX 23 she experienced injection site reaction 3 inches in diameter on her right arm that evening on (20-OCT-2014). The patient further reported that her right arm had become red, hard, swollen and hot (on 20-OCT-2014). This continued for the next 48 hours and she experienced headaches, sore throat, raspy sounding voice, general fatigue and sleeplessness (approximately on 22-OCT-2014). The patient was also unable to use her right arm (approximately on 20-OCT-2014). The outcome of adverse events was reported as recovering. The patient was treated with Arnica montana gel. No lab diagnostics studies were performed. The patient sought medical attention, called physician office. Additional information is not expected. No allowed to contact physician.
Information has been received from a nurse concerning a 53 year old female with a history of pneumonia in early 2008 who in April 2008, was vaccinated with a dose of PNEUMOVAX 23 vaccine. On 30-SEP-2009 the patient received another dose of PNEUMOVAX 23 vaccine (0.5ml, IM, lot# 662874/1125X) in her left arm. There as no concomitant medication. On 01-OCT-2009 the patient developed redness, warmth and tenderness of her upper left arm. The patient sought medical attention. At the time of the report, the patient was recovering. This is one of several reports received from the same source. Additional information has been requested.
Beginning Saturday morning, patient reports headache, unable to sleep, ringing in ears, not feeling hunger, strong feeling of his heartbeat, night sweats and an ache in his bones.
PT passed out in chair about 2 min after vaccine admin. states she saw spots prior to passing out. was in and out within about 5 seconds. mom and np caught pt in chair, she did not fall or hit her head. Came back and said she was feeling better. Np put cool washcloth  on head. mom states she gets nervous and weak prior to receiving vaccines
Blood in urine 24 hours after injection.; Triggers for urination; Threw up 3 time between waking and 48 hours after injection.; defecation seem turned on; 36 hours after injection woke up with digestive system distress.; This is a spontaneous report from a contactable consumer (patient). A 74-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: FN6198), via an unspecified route of administration, administered in left arm on 22Mar2021 04:00PM at the age of 74 years old as single dose for COVID-19 immunisation. The medical history included type 2 diabetic and 25 year colon cancer survivor and concomitant medication included Lipitor, Metformin, Vascepa, Jardiance, Trulicity. Allergies to medications, food, or other products: Demerol. On 23Mar2021 at 4: 00pm the patient had blood in urine 24 hours after injection. Triggers for urination and defecation seem turned on. Threw up 3 time between waking and 48 hours after injection. Began feeling better 52 hours after injection. The patient assessed the events as non-serious. The adverse event resulted in emergency room. Antibiotics were prescribed in treatment received in response to digestive system distress after 36 Hours. At the time of reporting the event was resolving.